<PAGE>
EXHIBIT 23.1
INDEPENDENT AUDITORS' CONSENT
The Board of Directors
Nexell Therapeutics Inc.:
We consent to the use of our report dated February 4, 2000, incorporated by
reference in the registration statement on Form S-3 of Nexell Therapeutics Inc.,
relating to the consolidated balance sheets of Nexell Therapeutics Inc. and
subsidiaries as of December 31, 1999 and 1998, and the related consolidated
statements of operations, changes in shareholders' equity and cash flows for
each of the years in the three-year period ended December 31, 1999, and to the
reference to our firm under the heading "Experts" in the prospectus.
/S/ KPMG LLP
Orange County, California
December 4, 2000
